A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis

NCT05692154 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Fexofenadine
DRUG: Placebo

Sponsor

Opella Healthcare Group SAS, a Sanofi Company